Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s13167-019-00175-0.

Title:
Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer | EPMA Journal
Description:
Relevance The pathogenesis and biomarkers of ovarian cancer (OC) remain not well-known in diagnosis, effective therapy, and prognostic assessment in OC personalized medicine. The novel identified lncRNA and mRNA biomarkers from gene co-expression modules associated with clinical traits provide new insight for effective treatment of ovarian cancer. Purpose Long non-coding RNAs (lncRNAs) are relevant to tumorigenesis via multiple mechanisms. This study aimed to investigate cancer-specific lncRNAs and mRNAs, and their related networks in OCs. Methods This study comprehensively analyzed lncRNAs and mRNAs with associated competing endogenous RNA (ceRNA) network and lncRNA–RNA binding protein–mRNA network in the OC tissues in the Cancer Genome Atlas, including 2562 cancer-specific lncRNAs (n = 352 OC tissues) and 5000 mRNAs (n = 359 OC tissues). The weighted gene co-expression network analysis (WGCNA) was used to construct the co-expression gene modules and their relationship with clinical traits. The statistically significant difference of identified lncRNAs and mRNAs was confirmed with qRT-PCR in OC cells. Results An lncRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tissues source site, and vascular invasion, and identified 16 lncRNAs (ACTA2-AS1, CARD8-AS1, HCP5, HHIP-AS1, HOTAIRM1, ITGB2-AS1, LINC00324, LINC00605, LINC01503, LINC01547, MIR31HG, MIR155HG, OTUD6B-AS1, PSMG3-AS1, SH3PXD2A-AS1, and ZBED5-AS1) that were significantly related to overall survival in OC patients. An mRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tumor residual disease, and vascular invasion; and identified 21 hub-mRNA molecules and 11 mRNAs (FBN3, TCF7L1, SBK1, TRO, TUBB2B, PLCG1, KIAA1549, PHC1, DNMT3A, LAMA1, and C10orf82) that were closely linked with OC patients’ overall survival. Moreover, the prognostic model of five-gene signature (OTUD6B-AS1, PSMG3-AS1, ZBED5-AS1, SBK1, and PLCG1) was constructed to predict risk score in OC patients. Furthermore, starBase bioinformatics constructed the lncRNA–miRNA–mRNA and lncRNA–RNA binding protein-mRNA networks in OCs. Conclusion These new findings showed that lncRNA-related networks in OCs are a useful resource for identification of biomarkers in OCs.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We're unsure if the website is profiting.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {šŸ”}

coexpression, module, cancer, lncrnas, mrnas, analysis, clinical, article, pubmed, modules, data, ovarian, gene, fig, network, google, scholar, mrna, genes, ocs, patients, invasion, biomarkers, diagnosis, identified, yellow, cell, including, lncrna, wgcna, linc, expression, binding, cells, based, correlation, table, mirp, rnas, score, central, effective, traits, molecular, cas, zhan, significantly, mrnabased, hubmrnas, supplementary,

Topics {āœ’ļø}

mir-29b-3p mir-29c-3p investigate lncrna–mirna–mrna networks large-scale clip-seq data lncrna–mirna–mrna networks full size image analyze network-interaction strength protein post-translational regulation article download pdf scale-free fit index encodes β-catenin protein lncrna–mirna–mrna network 4 μl rnase-free water 2 μl rnase-free water multi-parameter systematic strategies check scale-free topology scale-free topology model investigated oc-specific lncrna multi-molecule pattern biomarker ovarian cancer surgery—heed wnt-protein binding lncrna foxd2-as1 controlled lncrna foxd2-as1 accelerates kaplan–meier survival curves s100 protein binding scaffold protein binding wnt signaling pathway construct multi-molecule biomarkers quantitative real-time pcr clinical trait–related lncrna central south university adrenergic receptor binding lncrna-based brown module transcriptome-based pattern biomarkers lncrna-related networks culture tov-21g cells rna-binding proteins 17 rna-binding proteins multiple signaling pathways mrna-based yellow module lncrna–mirna–mrna statistically significant difference large-scale clinical samples investigate cancer-specific lncrnas multiomics-based pattern biomarker download original data identify oc-related module dnmt3a-dependent tolerogenic functions xianquan zhan discover therapeutic targets privacy choices/manage cookies

Questions {ā“}

  • How many proteins can be identified in a 2DE gel spot within an analysis of a complex human cancer tissue proteome?
  • Non-coding transcript variants of protein-coding genes - what are they good for?
  • Ovarian cancer treatment—are we getting warmer?

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
         description:The pathogenesis and biomarkers of ovarian cancer (OC) remain not well-known in diagnosis, effective therapy, and prognostic assessment in OC personalized medicine. The novel identified lncRNA and mRNA biomarkers from gene co-expression modules associated with clinical traits provide new insight for effective treatment of ovarian cancer. Long non-coding RNAs (lncRNAs) are relevant to tumorigenesis via multiple mechanisms. This study aimed to investigate cancer-specific lncRNAs and mRNAs, and their related networks in OCs. This study comprehensively analyzed lncRNAs and mRNAs with associated competing endogenous RNA (ceRNA) network and lncRNA–RNA binding protein–mRNA network in the OC tissues in the Cancer Genome Atlas, including 2562 cancer-specific lncRNAs (n = 352 OC tissues) and 5000 mRNAs (n = 359 OC tissues). The weighted gene co-expression network analysis (WGCNA) was used to construct the co-expression gene modules and their relationship with clinical traits. The statistically significant difference of identified lncRNAs and mRNAs was confirmed with qRT-PCR in OC cells. An lncRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tissues source site, and vascular invasion, and identified 16 lncRNAs (ACTA2-AS1, CARD8-AS1, HCP5, HHIP-AS1, HOTAIRM1, ITGB2-AS1, LINC00324, LINC00605, LINC01503, LINC01547, MIR31HG, MIR155HG, OTUD6B-AS1, PSMG3-AS1, SH3PXD2A-AS1, and ZBED5-AS1) that were significantly related to overall survival in OC patients. An mRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tumor residual disease, and vascular invasion; and identified 21 hub-mRNA molecules and 11 mRNAs (FBN3, TCF7L1, SBK1, TRO, TUBB2B, PLCG1, KIAA1549, PHC1, DNMT3A, LAMA1, and C10orf82) that were closely linked with OC patients’ overall survival. Moreover, the prognostic model of five-gene signature (OTUD6B-AS1, PSMG3-AS1, ZBED5-AS1, SBK1, and PLCG1) was constructed to predict risk score in OC patients. Furthermore, starBase bioinformatics constructed the lncRNA–miRNA–mRNA and lncRNA–RNA binding protein-mRNA networks in OCs. These new findings showed that lncRNA-related networks in OCs are a useful resource for identification of biomarkers in OCs.
         datePublished:2019-07-19T00:00:00Z
         dateModified:2019-07-19T00:00:00Z
         pageStart:273
         pageEnd:290
         sameAs:https://doi.org/10.1007/s13167-019-00175-0
         keywords:
            Ovarian cancer
            Co-expression module
            lncRNA
            mRNA
            WGCNA
            Diagnosis
            Prognostic assessment
            Predictive preventive personalized medicine (PPPM)
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig8_HTML.png
         isPartOf:
            name:EPMA Journal
            issn:
               1878-5085
               1878-5077
            volumeNumber:10
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Na Li
               affiliation:
                     name:Central South University
                     address:
                        name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Central South University
                     address:
                        name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Central South University
                     address:
                        name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xianquan Zhan
               url:http://orcid.org/0000-0002-4984-3549
               affiliation:
                     name:Central South University
                     address:
                        name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Central South University
                     address:
                        name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Central South University
                     address:
                        name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Central South University
                     address:
                        name:National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
      description:The pathogenesis and biomarkers of ovarian cancer (OC) remain not well-known in diagnosis, effective therapy, and prognostic assessment in OC personalized medicine. The novel identified lncRNA and mRNA biomarkers from gene co-expression modules associated with clinical traits provide new insight for effective treatment of ovarian cancer. Long non-coding RNAs (lncRNAs) are relevant to tumorigenesis via multiple mechanisms. This study aimed to investigate cancer-specific lncRNAs and mRNAs, and their related networks in OCs. This study comprehensively analyzed lncRNAs and mRNAs with associated competing endogenous RNA (ceRNA) network and lncRNA–RNA binding protein–mRNA network in the OC tissues in the Cancer Genome Atlas, including 2562 cancer-specific lncRNAs (n = 352 OC tissues) and 5000 mRNAs (n = 359 OC tissues). The weighted gene co-expression network analysis (WGCNA) was used to construct the co-expression gene modules and their relationship with clinical traits. The statistically significant difference of identified lncRNAs and mRNAs was confirmed with qRT-PCR in OC cells. An lncRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tissues source site, and vascular invasion, and identified 16 lncRNAs (ACTA2-AS1, CARD8-AS1, HCP5, HHIP-AS1, HOTAIRM1, ITGB2-AS1, LINC00324, LINC00605, LINC01503, LINC01547, MIR31HG, MIR155HG, OTUD6B-AS1, PSMG3-AS1, SH3PXD2A-AS1, and ZBED5-AS1) that were significantly related to overall survival in OC patients. An mRNA-based co-expression module was significantly correlated with patient age at initial pathologic diagnosis, lymphatic invasion, tumor residual disease, and vascular invasion; and identified 21 hub-mRNA molecules and 11 mRNAs (FBN3, TCF7L1, SBK1, TRO, TUBB2B, PLCG1, KIAA1549, PHC1, DNMT3A, LAMA1, and C10orf82) that were closely linked with OC patients’ overall survival. Moreover, the prognostic model of five-gene signature (OTUD6B-AS1, PSMG3-AS1, ZBED5-AS1, SBK1, and PLCG1) was constructed to predict risk score in OC patients. Furthermore, starBase bioinformatics constructed the lncRNA–miRNA–mRNA and lncRNA–RNA binding protein-mRNA networks in OCs. These new findings showed that lncRNA-related networks in OCs are a useful resource for identification of biomarkers in OCs.
      datePublished:2019-07-19T00:00:00Z
      dateModified:2019-07-19T00:00:00Z
      pageStart:273
      pageEnd:290
      sameAs:https://doi.org/10.1007/s13167-019-00175-0
      keywords:
         Ovarian cancer
         Co-expression module
         lncRNA
         mRNA
         WGCNA
         Diagnosis
         Prognostic assessment
         Predictive preventive personalized medicine (PPPM)
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13167-019-00175-0/MediaObjects/13167_2019_175_Fig8_HTML.png
      isPartOf:
         name:EPMA Journal
         issn:
            1878-5085
            1878-5077
         volumeNumber:10
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Na Li
            affiliation:
                  name:Central South University
                  address:
                     name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Central South University
                  address:
                     name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Central South University
                  address:
                     name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xianquan Zhan
            url:http://orcid.org/0000-0002-4984-3549
            affiliation:
                  name:Central South University
                  address:
                     name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Central South University
                  address:
                     name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Central South University
                  address:
                     name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Central South University
                  address:
                     name:National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:EPMA Journal
      issn:
         1878-5085
         1878-5077
      volumeNumber:10
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Central South University
      address:
         name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
      name:Central South University
      address:
         name:National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Na Li
      affiliation:
            name:Central South University
            address:
               name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Central South University
            address:
               name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Central South University
            address:
               name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xianquan Zhan
      url:http://orcid.org/0000-0002-4984-3549
      affiliation:
            name:Central South University
            address:
               name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Central South University
            address:
               name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Central South University
            address:
               name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Central South University
            address:
               name:National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:Hunan Engineering Laboratory for Structural Biology and Drug Design, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:State Local Joint Engineering Laboratory for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
      name:National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People’s Republic of China

External Links {šŸ”—}(191)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

5.17s.